← 產業報告目錄
Chronic Rhinosinusitis with Nasal Polyps Market Size, Share & Trends Analysis Report By Treatment Type (Pharmacological Treatments (Corticosteroids, Antibiotics, Biologic Drugs, Antihistamines, Leukotriene Modifiers), Surgical Interventions, Others), By Route of Administration (Oral, Nasal, Injectable), By Distribution (Direct Sales, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Specialized Clinics and ENT Practices, Ambulatory Surgical Centers)), by Region, And by Segment Forecasts, 2025-2034.
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-05頁數 180報告編號 INSIGHTACE-20e93c6474
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Chronic Rhinosinusitis with Nasal Polyps Market on a global scale was estimated at USD 1.8 Bn in 2024 and is anticipated to attain USD 3.4 Bn by 2034, with a projected CAGR of 6.6% between 2025 and 2034.
At its core, Chronic Rhinosinusitis with Nasal Polyps pertains to a disorder marked by benign inflammatory lesions called nasal polyps and ongoing sinus inflammation. Stakeholders across the healthcare landscape are risingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened need next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold notable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and rising investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Chronic Rhinosinusitis with Nasal Polyps Market Snapshot
Chapter 4. Global Chronic Rhinosinusitis with Nasal Polyps Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Chronic Rhinosinusitis with Nasal Polyps Market Industry Trends
4.10. Global Chronic Rhinosinusitis with Nasal Polyps Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Chronic Rhinosinusitis with Nasal Polyps Market Segmentation 1: By Treatment Type, Estimates & Trend Analysis
5.1. Market Share by Treatment Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Treatment Type:
5.2.1. Pharmacological Treatments
5.2.1.1. Corticosteroids
5.2.1.2. Biologic Drugs
5.2.1.3. Antibiotics
5.2.1.4. Antihistamines
5.2.1.5. Leukotriene Modifiers
5.2.2. Surgical Interventions
5.2.3. Other Therapies
Chapter 6. Chronic Rhinosinusitis with Nasal Polyps Market Segmentation 2: By Route of Administration, Estimates & Trend Analysis
6.1. Market Share by Route of Administration, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Route of Administration:
6.2.1. Oral Medications
6.2.2. Nasal Medications
6.2.3. Injectable Medications
Chapter 7. Chronic Rhinosinusitis with Nasal Polyps Market Segmentation 3: By Distribution Channel, Estimates & Trend Analysis
7.1. Market Share by Distribution Channel, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Distribution Channel:
7.2.1. Direct Sales
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
Chapter 8. Chronic Rhinosinusitis with Nasal Polyps Market Segmentation 4: By End User, Estimates & Trend Analysis
8.1. Market Share by End User, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
8.2.1. Hospitals
8.2.2. Specialized Clinics and ENT Practices
8.2.3. Ambulatory Surgical Centers
Chapter 9. Chronic Rhinosinusitis with Nasal Polyps Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Chronic Rhinosinusitis with Nasal Polyps Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2021-2034
9.2.3. North America Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.2.4. North America Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.2.5. North America Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.3. Europe
9.3.1. Europe Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2021-2034
9.3.3. Europe Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.3.4. Europe Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.3.5. Europe Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2021-2034
9.4.3. Asia Pacific Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.4.4. Asia Pacific Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.4.5. Asia Pacific Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.5. Latin America
9.5.1. Latin America Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2021-2034
9.5.3. Latin America Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.5.4. Latin America Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.5.5. Latin America Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2021-2034
9.6.3. Middle East & Africa Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2021-2034
9.6.4. Middle East & Africa Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.6.5. Middle East & Africa Chronic Rhinosinusitis with Nasal Polyps Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Regeneron Pharmaceuticals
10.2.1.1. Business Overview
10.2.1.2. Key Treatment Type/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Laboratory Corporation Of America Holdings Sanofi
10.2.3. GlaxoSmithKline
10.2.4. Novartis
10.2.5. AstraZeneca
10.2.6. Amgen
10.2.7. Hikma Pharmaceuticals
10.2.8. Eli Lilly
10.2.9. AbbVie
10.2.10. Pfizer
10.2.11. Others
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們